Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study
Titel:
Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study
Auteur:
Gordan, Lucio Navarro Tan, Carlyn Rose Vescio, Robert Ye, Jing Christine Schinke, Carolina Medhekar, Rohan Fu, Alex Z. Lafeuille, Marie-Hélène Thompson-Leduc, Philippe Khare, Vipin Reitan, John Milkovich, Gary Kaila, Shuchita Davies, Faith Usmani, Saad Z.